SW
ARKG icon

SVB Wealth’s ARK Genomic Revolution ETF ARKG Stock Holding History

SVB Wealth’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-71
Closed -$1.48K – 542
2025
Q1 		$1.48K Buy
+71
New +$1.78K ﹤0.01% 1289
2021
Q4 		– Sell
-193
Closed -$14K – 819
2021
Q3 		$14K Sell
193
-25
-11% -$2.1K ﹤0.01% 985
2021
Q2 		$20K Buy
218
+25
+13% +$2.13K ﹤0.01% 961
2021
Q1 		$17K Buy
+193
New +$19.1K ﹤0.01% 903

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SVB Wealth's ARKG Position: Q2 2025 in Review

SVB Wealth sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2025, closing a stake of 71 shares — an estimated $1.48K sold.

SVB Wealth first reported a position in ARKG in Q1 2021 and held it in 4 quarters. The position peaked at $20K in Q2 2021. 213 funds tracked by Wall St. Rank hold ARKG as of Q2 2025.

  • SVB Wealth reported no remaining ARK Genomic Revolution ETF position as of Q2 2025 after selling out during the quarter.
  • SVB Wealth sold 71 ARK Genomic Revolution ETF shares in Q2 2025, an estimated $1.48K.
  • SVB Wealth first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 4 quarters.
  • SVB Wealth's ARK Genomic Revolution ETF position peaked at $20K in Q2 2021.
  • 213 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2025.

Based on SVB Wealth's 13F filing for Q2 2025, filed 14 Aug 2025.